BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 29695519)

  • 21. Performance evaluation of EuDx™ ufPCR Flu & RSV detection kit for detection of influenza A/B and respiratory syncytial virus.
    Lim YK; Kweon OJ; Kim HR; Kim TH; Cho AR; Lee MK
    J Microbiol Immunol Infect; 2021 Jun; 54(3):518-521. PubMed ID: 32616379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a rapid antigen detection point-of-care test for respiratory syncytial virus and influenza in a pediatric hospitalized population in the Netherlands.
    Bruning AH; van Dijk K; van Eijk HW; Koen G; van Woensel JB; Kruisinga FH; Pajkrt D; Wolthers KC
    Diagn Microbiol Infect Dis; 2014 Dec; 80(4):292-3. PubMed ID: 25241640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of multiplex RT-PCR assays for the detection of influenza A/B and respiratory syncytial virus using a high throughput system.
    Eigner U; Reucher S; Hefner N; Staffa-Peichl S; Kolb M; Betz U; Holfelder M; Spier G; Pfefferle S; Lütgehetmann M
    J Virol Methods; 2019 Jul; 269():49-54. PubMed ID: 30946852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter Clinical Evaluation of the Luminex Aries Flu A/B & RSV Assay for Pediatric and Adult Respiratory Tract Specimens.
    Juretschko S; Mahony J; Buller RS; Manji R; Dunbar S; Walker K; Rao A
    J Clin Microbiol; 2017 Aug; 55(8):2431-2438. PubMed ID: 28539342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cepheid Xpert Xpress Flu/RSV evaluation performed by minimally trained non-laboratory operators in a CLIA-waived environment.
    Shihabuddin BS; Faron ML; Relich RF; Van Heukelom P; Mayne D; Staat MA; Selvarangan R; Hueschen LA; Wolk DM; House S; Harnett G; McGann K; Steele MT; Romero JR; Arms J; Lander O; Loeffelholz M; Strouts F; Cohen D
    Diagn Microbiol Infect Dis; 2022 Oct; 104(2):115764. PubMed ID: 35917666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Near point-of-care administration by the attending physician of the rapid influenza antigen detection immunochromatography test and the fully automated respiratory virus nucleic acid test: contribution to patient management.
    Boku S; Naito T; Murai K; Tanei M; Inui A; Nisimura H; Isonuma H; Takahashi H; Kikuchi K
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):445-9. PubMed ID: 23743175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical evaluation of a novel and simple-to-use molecular platform for diagnosis of respiratory syncytial virus.
    Liikonen K; Ojalehto T; Elf S; Mäki M; Matero P; Eboigbodin KE
    Anal Biochem; 2018 Jun; 551():4-6. PubMed ID: 29680224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic performance and clinical feasibility of a point-of-care test for respiratory viral infections in primary health care.
    Bruning AHL; de Kruijf WB; van Weert HCPM; Willems WLM; de Jong MD; Pajkrt D; Wolthers KC
    Fam Pract; 2017 Sep; 34(5):558-563. PubMed ID: 28369370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the Cepheid Xpert Xpress Flu/RSV Assay to in-house Flu/RSV triplex real-time RT-PCR for rapid molecular detection of Influenza A, Influenza B and Respiratory Syncytial Virus in respiratory specimens.
    Ho YII; Wong AH; Lai RWM
    J Med Microbiol; 2018 Nov; 67(11):1576-1580. PubMed ID: 30207514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-time detection of influenza a, influenza B, and respiratory syncytial virus a and B in respiratory specimens by use of nanoparticle probes.
    Jannetto PJ; Buchan BW; Vaughan KA; Ledford JS; Anderson DK; Henley DC; Quigley NB; Ledeboer NA
    J Clin Microbiol; 2010 Nov; 48(11):3997-4002. PubMed ID: 20826644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of implementing respiratory point-of-care testing in a regional haemato-oncology unit.
    Goldstein EJ; Dhillon R; McCullough C; Inkster T; Soutar R; Gunson RN
    J Hosp Infect; 2020 Sep; 106(1):20-24. PubMed ID: 32569673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of Four sample-to-answer influenza A/B and RSV nucleic acid amplification assays using adult respiratory specimens.
    Banerjee D; Kanwar N; Hassan F; Lankachandra K; Selvarangan R
    J Clin Virol; 2019 Sep; 118():9-13. PubMed ID: 31302479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Alinity m Resp-4-Plex Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2, Influenza A Virus, Influenza B Virus, and Respiratory Syncytial Virus.
    Zhen W; Manji R; Smith E; Wuitschick J; Lucic D; Berry GJ
    Microbiol Spectr; 2022 Feb; 10(1):e0109021. PubMed ID: 35107357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance evaluation of four rapid antigen tests for the detection of Respiratory syncytial virus.
    Jung BK; Choi SH; Lee JH; Lee J; Lim CS
    J Med Virol; 2016 Oct; 88(10):1720-4. PubMed ID: 26990654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter Evaluation of the ePlex Respiratory Pathogen Panel for the Detection of Viral and Bacterial Respiratory Tract Pathogens in Nasopharyngeal Swabs.
    Babady NE; England MR; Jurcic Smith KL; He T; Wijetunge DS; Tang YW; Chamberland RR; Menegus M; Swierkosz EM; Jerris RC; Greene W
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29212701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance evaluation of a rapid molecular diagnostic, MultiCode based, sample-to-answer assay for the simultaneous detection of Influenza A, B and respiratory syncytial viruses.
    Voermans JJ; Seven-Deniz S; Fraaij PL; van der Eijk AA; Koopmans MP; Pas SD
    J Clin Virol; 2016 Dec; 85():65-70. PubMed ID: 27835760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter evaluation of molecular point-of-care testing and digital immunoassays for influenza virus A/B and respiratory syncytial virus in patients with influenza-like illness.
    Kaku N; Kodama H; Akamatsu N; Ota K; Kosai K; Morinaga Y; Narita Y; Matsumoto Y; Matsushita T; Mizuta Y; Izumikawa K; Mukae H; Yanagihara K
    J Infect Chemother; 2021 Jun; 27(6):820-825. PubMed ID: 33509674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of commercial rapid respiratory virus diagnostic tests on patient outcomes and health system utilization.
    Ko F; Drews SJ
    Expert Rev Mol Diagn; 2017 Oct; 17(10):917-931. PubMed ID: 28841814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput.
    Phan T; Tran NYK; Gottlieb T; Siarakas S; McKew G
    Pathology; 2022 Jun; 54(4):466-471. PubMed ID: 35461715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective study to assess the diagnostic performance of the Sofia(®) Immunoassay for Influenza and RSV detection.
    Gomez S; Prieto C; Folgueira L
    J Clin Virol; 2016 Apr; 77():1-4. PubMed ID: 26872325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.